Control Bionics is all set to launch its NeuroNode Trilogy technology in Japan in partnership with major assistive technology distributor, Double R&D Co Ltd, under an initiative led by CBL’s Japanese executive, Erica Kitayama.
CBL has advanced the deal to provide its technology benefits to Japanese people with medical conditions such as ALS, cerebral palsy, intellectual disability, stroke and traumatic brain injuries.
It can be tricky to navigate the healthcare system in Canada, so we talked to experts in three new webinars.
Strategic Partnership Offers Customers More Access to Control Bionics’ Industry-Leading Trilogy Product Line. (Milford, OH and New South Wales, AU) – Control Bionics, a global assistive
USA
745 Center Street, Suite 303
Milford OH 45150
AUSTRALIA
697 Burke Road, Level 5, Suite 5.01
Camberwell VIC 3124
CANADA
Bridges Canada
2123 McCowan Road
Scarborough, Ontario M1S 3Y6
JAPAN
©2012-2023 Control Bionics, Inc. All Rights Reserved
